Detalhe da pesquisa
1.
Cellular and animal models for the investigation of ß-thalassemia.
Blood Cells Mol Dis
; 104: 102761, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271682
2.
Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in ß-thalassemic mice.
Am J Hematol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629683
3.
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Kidney Int
; 104(1): 61-73, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990212
4.
Correcting ß-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Blood
; 136(17): 1968-1979, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556142
5.
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent ß-thalassemia.
Am J Hematol
; 97(10): 1324-1336, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071579
6.
Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients.
Am J Hematol
; 96(1): E32-E35, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33075189
7.
SELENON (SEPN1) protects skeletal muscle from saturated fatty acid-induced ER stress and insulin resistance.
Redox Biol
; 24: 101176, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30921636